Global Warfarin Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: May 17, 2021 |

The global warfarin market size is expected to grow at a significant CAGR of 2.4% during the forecast period from 2021 to 2027 and anticipated to reach at USD 2,732 million by 2027. The significant increase in the number of people suffering from atrial fibrillation worldwide. Effective implementation of treatment guidelines pertaining to the management of DVT/PE further accentuates the warfarin market growth.

Warfarin is classified as an anticoagulant which is used to prevent the formation of blood clot and migraine. It needs to be taken under medical supervision as the drug has the capacity to cross the placental barrier during pregnancy which can eventually result in preterm birth, spontaneous abortion, artery calcification, and osteoporosis. It is a vitamin K antagonist which inhibits its production by the vitamin K epoxide reductase.

Market Segment Insights:

Atrial fibrillation is currently dominating the clinical application segment for the warfarin market. As per the latest information provided by the National Institute of Health (NIH), approximately 0.5% of the global population is suffering from atrial fibrillation. Further clinical analysis provides the factors responsible for the occurrence of atrial fibrillation such as congenital heart defects, coronary artery diseases, high intake of caffeine, tobacco, alcohol, etc. DVT/PE will be highlighting comfortable market growth in the near future on account of the growing prevalence rate in the elderly population worldwide. According to the recent information provided by the International Society on Thrombosis and Haemostasis (ISTH) annually 10 million new cases are reported worldwide to be suffering from venous thromboembolism. The clinical manifestations associated with the venous thromboembolism are shortness of breath, chest pain swelling of foot and ankles, pain and tenderness in the calf region, lightheadedness, etc.

Warfarin Market Size & CAGR

To know more about the study, request a report sample

Hospital pharmacy is presently leading the distribution channel segment for the warfarin market. The drug toxicity associated with the warfarin overdose makes it mandatory for its precise compounding under the supervision of a hospital pharmacist. Retail pharmacy is expected to garner impressive market performance during the forecast period owing to the availability of affordable essential medicines due to government subsidy and its capacity to provide medicinal requirements to households residing in remote locations.

The warfarin comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market, and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The warfarin market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Warfarin Market Segmentation:

By Clinical Application:

  • Atrial Fibrillation
  • DVT/PE
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

North America is representing the largest market share in the regional segment for the warfarin market. The rising prevalence of cardiac diseases primarily drives the warfarin market growth in the region. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), it is estimated that by 2030 the number of individuals suffering from atrial fibrillation will be 12.1 million in the United States. The existence of well-developed healthcare infrastructure and favorable reimbursement scenario associated with the use of warfarin drug formulation together propels the market growth in the region. Europe is considered as the second-largest regional segment for the warfarin market on account of the growing incidence of deep vein thrombosis in the elderly patients in the region. Additionally, the nurturing regulatory environment provided by the European Medical Agency (EMA), regarding the sale and distribution of warfarin in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for the warfarin market owing to the effective implementation of treatment guidelines regarding cardiovascular diseases by the local healthcare agencies and the flourishing generic drugs market.

Market Competition Assessment:

Some of the major players operating in the global Warfarin market are Bristol-Myers Squibb Company, Apotex Corporation, Zydus Healthcare, Cipla Limited, and Teva Pharmaceutical Industries Limited. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Bristol-Myers Squibb Company
  • Apotex Corporation
  • Upsher-Smith Laboratories, LLC
  • Zydus Healthcare
  • Cipla Limited
  • Orion Pharma
  • Teva Pharmaceutical Industries Limited
  • Mylan Pharmaceutical Industries Limited
  • Taro Pharmaceutical Industries Ltd.
  • IPCA Labs Ltd.

Key Questions Answered by Warfarin Market Report:

  • Global warfarin market forecasts from 2021-2027
  • Regional warfarin market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Warfarin submarket forecasts from 2021-2027 covering the market by clinical application, by distribution channel, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the warfarin market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level warfarin markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the warfarin market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Warfarin Market Portraiture
2.2. Global Warfarin Market, by Clinical Application, 2020 (USD Mn)
2.3. Global Warfarin Market, by Distribution Channel, 2020 (USD Mn)
2.4. Global Warfarin Market, by Geography, 2020 (USD Mn)

 

3. Global Warfarin Market Analysis


3.1. Warfarin Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

 

4. Global Warfarin Market By Clinical Application, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. Atrial Fibrillation
4.3. DVT/PE
4.4. Others

 

5. Global Warfarin Market By Distribution Channel, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Hospital Pharmacy
5.3. Retail Pharmacy
5.4. Others

 

6. North America Warfarin Market Analysis and Forecast, 2018 – 2027 (USD Mn)


6.1.1. Overview
6.1.2. North America Warfarin Market by Clinical Application (2018-2027 USD Mn)
6.1.3. North America Warfarin Market by Distribution Channel (2018-2027 USD Mn)
6.1.4. North America Warfarin Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.1.1. U.S. Warfarin Market by Clinical Application (2018-2027 USD Mn)
6.1.4.1.2. U.S. Warfarin Market by Distribution Channel (2018-2027 USD Mn)
6.1.4.2. Canada
6.1.4.2.1. Canada Warfarin Market by Clinical Application (2018-2027 USD Mn)
6.1.4.2.2. Canada Warfarin Market by Distribution Channel (2018-2027 USD Mn)

 

7. Europe Warfarin Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. Europe Warfarin Market by Clinical Application (2018-2027 USD Mn)
7.1.3. Europe Warfarin Market by Distribution Channel (2018-2027 USD Mn)
7.1.4. Europe Warfarin Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.1.1. Germany Warfarin Market by Clinical Application (2018-2027 USD Mn)
7.1.4.1.2. Germany Warfarin Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.2. U.K.
7.1.4.2.1. U.K. Warfarin Market by Clinical Application (2018-2027 USD Mn)
7.1.4.2.2. U.K. Warfarin Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.3. France
7.1.4.3.1. France Warfarin Market by Clinical Application (2018-2027 USD Mn)
7.1.4.3.2. France Warfarin Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.4. Italy
7.1.4.4.1. Italy Warfarin Market by Clinical Application (2018-2027 USD Mn)
7.1.4.4.2. Italy Warfarin Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.5. Rest of Europe
7.1.4.5.1. Rest of Europe Warfarin Market by Clinical Application (2018-2027 USD Mn)
7.1.4.5.2. Rest of Europe Warfarin Market by Distribution Channel (2018-2027 USD Mn)

 

8. Asia Pacific Warfarin Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Asia Pacific Warfarin Market by Clinical Application (2018-2027 USD Mn)
8.1.3. Asia Pacific Warfarin Market by Distribution Channel (2018-2027 USD Mn)
8.1.4. Asia Pacific Warfarin Market by Country (2018-2027 USD Mn)
8.1.4.1. China
8.1.4.1.1. China Warfarin Market by Clinical Application (2018-2027 USD Mn)
8.1.4.1.2. China Warfarin Market by Distribution Channel (2018-2027 USD Mn)
8.1.4.2. Japan
8.1.4.2.1. Japan Warfarin Market by Clinical Application (2018-2027 USD Mn)
8.1.4.2.2. Japan Warfarin Market by Distribution Channel (2018-2027 USD Mn)
8.1.4.3. Rest of Asia Pacific
8.1.4.3.1. Rest of Asia Pacific Warfarin Market by Clinical Application (2018-2027 USD Mn)
8.1.4.3.2. Rest of Asia Pacific Warfarin Market by Distribution Channel (2018-2027 USD Mn)

 

9. Latin America (LATAM) Warfarin Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Latin America Warfarin Market by Clinical Application (2018-2027 USD Mn)
9.1.3. Latin America Warfarin Market by Distribution Channel (2018-2027 USD Mn)
9.1.4. Latin America Warfarin Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.1.1. Brazil Warfarin Market by Clinical Application (2018-2027 USD Mn)
9.1.4.1.2. Brazil Warfarin Market by Distribution Channel (2018-2027 USD Mn)
9.1.4.2. Mexico
9.1.4.2.1. Mexico Warfarin Market by Clinical Application (2018-2027 USD Mn)
9.1.4.2.2. Mexico Warfarin Market by Distribution Channel (2018-2027 USD Mn)
9.1.4.3. Rest of Latin America
9.1.4.3.1. Rest of Latin America Warfarin Market by Clinical Application (2018-2027 USD Mn)
9.1.4.3.2. Rest of Latin America Warfarin Market by Distribution Channel (2018-2027 USD Mn)

 

10. Middle East and Africa Warfarin Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. MEA Warfarin Market by Clinical Application (2018-2027 USD Mn)
10.1.3. MEA Warfarin Market by Distribution Channel (2018-2027 USD Mn)
10.1.4. Middle East and Africa Warfarin Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.1.1. GCC Warfarin Market by Clinical Application (2018-2027 USD Mn)
10.1.4.1.2. GCC Warfarin Market by Distribution Channel (2018-2027 USD Mn)
10.1.4.2. Rest of MEA
10.1.4.2.1. Rest of MEA Warfarin Market by Clinical Application (2018-2027 USD Mn)
10.1.4.2.2. Rest of MEA Warfarin Market by Distribution Channel (2018-2027 USD Mn)

 

11. Company Profiles


11.1. Bristol-Myers Squibb Company
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. Apotex Corporation
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. Upsher-Smith Laboratories, LLC
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. Zydus Healthcare
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Cipla Limited
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. Orion Pharma
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Teva Pharmaceutical Industries Limited
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Mylan Pharmaceutical Industries Limited
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. Taro Pharmaceutical Industries Ltd.
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. IPCA Labs Ltd.
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Warfarin Market Report

Your Designtaion (required):


(Additional country analysis and conmapny analysis will be added according to request, please read our FAQs below:)(Reports covers the COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying



Frequently Asked Questions (FAQs):
A. Yes, we provide customization with every report to fulfill your market research requirement.
A. No, generally we don’t charge for report customization.
A. Yes, we will add the more coutries analysis in the report, please mention the countries you are looking.
A. Yes, we provide research support for all our clients to resolve their issue regarding the report.
A. Yes, you can purchase only a regional or a country market report with our best price which is less than the global report.
A. Yes, we provide a better discount for startups and individuals.
A. Our database consists of over 70,000 market research reports; if still not available on the website, feel free to write us. Our team will be happy to assist you in the same. Let us know if you are looking for the dataset.
(For more information, feel free to write us at sales@researchcorridor.com)
Select License Type
$3600/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client are returning clients
  • 100,000+ data points in our comprehensive database
  • 24x5 availability - we are always there when you need us
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report

Impacts of COVID-19
COVID-19 Impact on the Warfarin Market

For Any Assitance

Call Us: +1 520-686-7060
Email: sales@researchcorridor.com

Our Clients